What is Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (300401.SZ) StockRank?

MoatMap's StockRank for Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) is 54/100, with a Hold signal. This is a composite score combining Quality (55), Value (31), and Momentum (58) factor ranks across MoatMap's 19,000+ stock universe.

Does Zhejiang Garden Biopharmaceutical Co.,Ltd. have an economic moat?

Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Zhejiang Garden Biopharmaceutical Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Zhejiang Garden Biopharmaceutical Co.,Ltd. in?

Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300401.SZ

HOLDFLAG

Zhejiang Garden Biopharmaceutical Co.,Ltd. · Healthcare · China · $984M · Avg Vol: $42M/d

StockRank

P/E (TTM)

34.9x

ROE

7.5%

D/E

0.5x

Dividend %

0.8%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Zhejiang Garden Biopharma is a major producer of Vitamin D3 and pharmaceutical intermediates. While it benefits from supply consolidation and regulatory compliance in the API space, it operates more as a cyclical chemical producer than a high-moat, asset-light CDMO, limiting our long-term conviction.

COMPANY DESCRIPTION

Zhejiang Garden Biopharmaceutical Co., Ltd. is the world's largest manufacturer of Vitamin D3, producing both feed-grade and pharmaceutical-grade formulations. The company possesses a highly competitive, vertically integrated industrial chain from NF-grade cholesterol to Vitamin D3 and its active analogues. This integration allows it to maintain significant cost leadership and pricing power in the global nutritional and pharmaceutical markets.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	209M	162M	184M	183M	-4.4%
EPS	0.10	0.05	0.08	0.08	-7.2%
Shares	551M	551M	543M	543M	-1.4%
Debt	92M	248M	267M	259M	40.9%
Equity	380M	428M	476M	516M	10.7%
Op CF	56M	24M	69M	70M	8.0%
Inv CF	-55M	-51M	-103M	-90M	—
Fin CF	7M	154M	16M	-31M	—

PRICE (1M)+17.2%

SMA 50SMA 200

$2.28

RSI (14)

73.9

52W High

$2.88

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

8.0%67.1

ROE

7.5%64.5

GP/Assets

11.0%27.8

Op. Margin

24.1%87.5

FCF/Assets

-0.5%49.2

Piotroski

—83.5

Int. Cover

11.9x67.0

D/E Ratio

0.49x31.8

Current Ratio

2.08x38.3

Value

P/E (TTM)

34.9x31.3

EV/EBITDA

15.2x27.3

P/FCF

—N/A

P/B

2.2x51.3

P/S

6.7x33.4

Div Yield

0.8%22.6

Momentum

52W High %

79%72.8

RS 6M

4%79.4

SMA 50/200

0.91x37.0

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—69.9

Q Growth

-48%10.9

FUNDAMENTALS

Market Cap

$984M

P/E (Forward)

18.1x

Gross Margin

53.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300401.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300401.SZ	Zhejiang Garden Biopharmaceutical Co.,Ltd.(you)	$984M	54	HOLD
301393.SZ	Suzhou Highfine Biotech Co., Ltd.	$896M	55	HOLD
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.	$1.1B	55	HOLD
688799.SS	Hunan Warrant Pharmaceutical Co.,Ltd	$975M	50	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
2186.HK	Luye Pharma Group Ltd.	$1.1B	61	HOLD
000597.SZ	Northeast Pharmaceutical Group Co., Ltd.	$983M	64	HOLD
600195.SS	China Animal Husbandry Industry Co., Ltd.	$996M	64	HOLD
300725.SZ	PharmaBlock Sciences (Nanjing), Inc.	$1.2B	60	HOLD
688073.SS	Bide Pharmatech Co., Ltd.	$683M	57	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) — Stock Score Summary

Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) has a MoatMap StockRank of 54/100 based on Quality (55/100), Value (31/100), and Momentum (58/100) factor scores. The current signal is HOLD. Zhejiang Garden Biopharma is a major producer of Vitamin D3 and pharmaceutical intermediates. While it benefits from supply consolidation and regulatory compliance in the API space, it operates more as a cyclical chemical producer than a high-moat, asset-light CDMO, limiting our long-term conviction.

Key Financial Metrics

Price	$2.28
Market Cap	$984M
P/E (TTM)	34.88
P/E (Forward)	18.09
Price/Book	2.25
Return on Equity	7.5%
Return on Invested Capital	8.0%
Debt/Equity	48.95
Gross Margin	53.2%
Operating Margin	24.1%
Revenue Growth	-15.2%
Dividend Yield	0.8%
Free Cash Flow	$-579K

Zhejiang Garden Biopharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Garden Biopharmaceutical Co.,Ltd.’s (300401.SZ) StockRank?: MoatMap’s StockRank for Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) is 54/100, with a Hold signal. It is a composite of Quality (55), Value (31), and Momentum (58) factor ranks across MoatMap’s 19,000+ stock universe.
Does Zhejiang Garden Biopharmaceutical Co.,Ltd. have an economic moat?: Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Garden Biopharmaceutical Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Garden Biopharmaceutical Co.,Ltd. in?: Zhejiang Garden Biopharmaceutical Co.,Ltd. (300401.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).